N	Concordance
1	lood progenitor cells were harvested by leukapheresis using an automated continu
2	 lly within 21 days after completion of leukapheresis and the second course 21-3
3	 that reliably predicts the efficacy of leukapheresis in these patients. We foun
4	tive bone  marrow harvest or outpatient leukapheresis. After hospitalization, a
5	nsistently resulting in cell yields per leukapheresis (LA) procedure that are su
6	for adoptive immunotherapy by selective leukapheresis (lymphocytapheresis).     
7	ransplantation procedure using standard leukapheresis products in very small chi
8	ipheral blood predicts the yield of the leukapheresis product and can replace pr
9	 rapidly in acute leukemia, therapeutic leukapheresis can prevent associated cer
10	ze peripheral blood stem cells prior to leukapheresis for use in autologous and 
11	ot engraft or encounter difficulty with leukapheresis, the  study will be closed